Loading…

Baseline requirements for novel agents being considered for phase II/III brain cancer efficacy trials: conclusions from the Adult Brain Tumor Consortium’s first workshop on CNS drug delivery

Saved in:

Bibliographic Details
Published in:	Neuro-oncology (Charlottesville, Va.) Va.), 2020-10, Vol.22 (10), p.1422-1424
Main Authors:	Grossman, Stuart A, Romo, Carlos G, Rudek, Michelle A, Supko, Jeffrey, Fisher, Joy, Nabors, L Burt, Wen, Patrick Y, Peereboom, David M, Ellingson, Benjamin M, Elmquist, William, Barker, Fred G, Kamson, David, Sarkaria, Jann N, Timmer, William, Bindra, Ranjit S, Ye, Xiaobu
Format:	Article
Language:	English
Subjects:	Adult Brain Neoplasms - drug therapy Clinical Trials, Phase II as Topic Clinical Trials, Phase III as Topic Drug Delivery Systems Humans Pharmaceutical Preparations Workshop Summary
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!